The Effect of Sulfasalazine on CRH Levels in Pregnant Women

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions

Preterm Birth

Interventions

DRUG

Sulfasalazine

Sulfasalazine will be administered between 24 and 36 weeks of pregnancy

Trial Locations (1)

RECRUITING

Rutgers Robert Wood Johnson Medical School, New Brunswick

All Listed Sponsors

lead

Rutgers, The State University of New Jersey

OTHER